| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $558.0M | — | +27.4% |
| Cost of Revenue | $283.0M | — | +22.5% |
| Gross Profit | $275.0M | — | +32.9% |
| R&D Expense | $323.0M | — | +17.5% |
| SG&A Expense | $31.0M | — | +72.2% |
| Operating Income | -$3.90B | — | -3229.9% |
| Pre-tax Income | -$3.88B | — | -3821.2% |
| Income Tax | -$64.0M | — | -2233.3% |
| Net Income | -$3.82B | — | -3643.1% |
| EPS (Basic) | -$4.68 | — | -3500.0% |
| EPS (Diluted) | -$4.68 | — | -3500.0% |
| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.21B | -34.0% | -19.9% |
| Accounts Receivable | $226.0M | +72.5% | +4.1% |
| Inventory | $303.0M | -7.3% | -16.8% |
| Current Assets | $1.99B | -19.6% | -10.0% |
| Total Assets | $8.73B | -30.1% | -30.1% |
| Current Liabilities | $419.0M |
| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $75.0M | — | -31.2% |
| Capital Expenditures | $30.0M | — | +114.3% |
| Investing Cash Flow | -$699.0M | — | -2696.0% |
| Financing Cash Flow | $0 | — | -100.0% |
| Free Cash Flow | $45.0M | — | -52.6% |
| +44.5% |
| Total Liabilities | $571.0M | -6.5% | +27.2% |
| Stockholders' Equity | $8.16B | -31.3% | -32.2% |